Impact BioMedical Q1 EPS $(0.02) Up From $(0.11) YoY, Sales $7.000K

Benzinga Newsdesk www.benzinga.com Negative 57.0%

Neg 57% Neu 0% Pos 0%

Impact BioMedical (AMEX:IBO) reported quarterly losses of $(0.02) per share. This is a 81.82 percent increase over losses of $(0.11) per share from the same period last year. The company reported $7.000 thousand in sales this quarter.